Iparomlimab and Tuvonralimab Injection Combined With SBRT in Patients With Early-Stage Non-Small Cell Lung Cancer
Clinical trial NCT07379398 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07379398
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2029-06-30
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.